Invezz
Bad news for Novo Nordisk weight-loss drug Wegovy
Novo Nordisk A/S (CPH: NOVO-B) is in the green today even though a Harvard study said its weight loss drug may increase the risk of nonarteritic anterior ischemic optic neuropathy (NAION). Are ...
2 days ago